Jackson Acquisition Company (RJAC)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Jackson Acquisition Company (RJAC) trades at $10.39 with AI Score 44/100 (Grade C). Jackson Acquisition Company is a blank check company formed to pursue a merger, share exchange, asset acquisition, stock purchase, or similar business combination. Market cap: $288.97M, Sector: Financial services.
Price live · AI analysis from Mar 17, 2026Analyst Coverage for RJAC: RJAC does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates RJAC against Financial Services peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
RJAC: the 1 perspectives are evenly split.
How is this calculated? →Jackson Acquisition Company (RJAC) Financial Services Profile
Jackson Acquisition Company, a special purpose acquisition company (SPAC), seeks to identify and merge with a business in the healthcare services or technology sectors. Founded in 2021, RJAC offers investors exposure to potential high-growth opportunities through its acquisition strategy, operating with a current market capitalization of $288.97M.
What Is the Investment Thesis for RJAC?
Jackson Acquisition Company presents an investment proposition centered on its ability to identify and merge with a promising healthcare services or technology company. The company's focus on these sectors aligns with long-term growth trends driven by an aging population, technological advancements, and increasing healthcare spending. Key value drivers include the management team's experience in deal sourcing and execution, as well as the attractiveness of the target company's business model and growth potential. The company's current P/E ratio is 25.12. A successful acquisition could lead to significant stock appreciation, while failure to complete a deal within the specified timeframe could result in liquidation and return of capital to shareholders. The company's ability to navigate the competitive SPAC landscape and secure a favorable transaction is crucial to its success.
Based on FMP financials and quantitative analysis
RJAC Key Highlights
- Jackson Acquisition Company focuses on the healthcare services and healthcare technology sectors.
- The company was founded in 2021 and is based in Alpharetta, Georgia.
- Jackson Acquisition Company has a market capitalization of $288.97M.
- The company's P/E ratio is 25.12.
- Jackson Acquisition Company does not currently offer a dividend.
Who Are RJAC's Competitors?
RJAC is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ACAC Acri Capital Acquisition Corporation | $11.20 | -4.44% | $44.48M | 44 |
| ALOR ALSP Orchid Acquisition Corporation I | $10.88 | -0.64% | $78.60M | 44 |
| ALSA Alpha Star Acquisition Corporation | $12.06 | +0.00% | $49.54M | 44 |
| ASCB A SPAC II Acquisition Corporation | $11.19 | +100.00% | $62.89M | 44 |
| NSH NavSight Holdings, Inc. | $9.93 | +3.01% | 69 | |
| LRGR Luminar Media Group, Inc. | $0.50 | +47.06% | $22.39M | 68 |
| LMAOU LMF Acquisition Opportunities, Inc. | $12.46 | +41.59% | 68 | |
| APXTW Apex Treasury Corporation | $0.37 | +5.11% | $1.96B | 66 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are RJAC's Key Strengths?
- Experienced management team
- Focus on high-growth sectors
- Access to public capital markets
- Flexibility to pursue various transaction structures
What Are RJAC's Weaknesses?
- Dependence on identifying and completing a successful acquisition
- Competition from other SPACs
- Potential for dilution of shareholder value
- Limited operating history
What Could Drive RJAC Stock Higher?
- Announcement of a definitive agreement to merge with a target company in the healthcare services or healthcare technology sectors.
- Progress in identifying and evaluating potential acquisition targets.
- Favorable market conditions for SPAC mergers and acquisitions.
What Are the Key Risks for RJAC?
- Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Failure to identify and complete a suitable acquisition within the specified timeframe, leading to liquidation.
- Increased competition from other SPACs for attractive acquisition targets.
- Economic downturn or market volatility impacting the valuation of potential acquisition targets.
- Changes in regulatory environment affecting the SPAC market and healthcare industry.
What Are the Growth Opportunities for RJAC?
- Acquisition of a High-Growth Healthcare Technology Company: Jackson Acquisition Company's primary growth opportunity lies in successfully acquiring a high-growth healthcare technology company. The global healthcare technology market is projected to reach $662 billion by 2028, growing at a CAGR of 13.5%. By merging with a company that has a strong product offering, a large addressable market, and a proven business model, Jackson Acquisition Company can create significant value for its shareholders. The timeline for this opportunity is dependent on the company's ability to identify and complete a transaction, which is expected within the next 12-24 months.
- Expansion into Telehealth Services: The telehealth market is experiencing rapid growth, driven by increasing demand for remote healthcare services and advancements in technology. Jackson Acquisition Company could explore opportunities to acquire or merge with a telehealth company to capitalize on this trend. The global telehealth market is projected to reach $55.6 billion by 2027, growing at a CAGR of 25.9%. This expansion could provide Jackson Acquisition Company with a new revenue stream and enhance its growth prospects. The timeline for this opportunity is dependent on the company's strategic priorities and market conditions.
- Strategic Partnerships with Healthcare Providers: Jackson Acquisition Company could pursue strategic partnerships with healthcare providers to gain access to new markets and customers. By collaborating with hospitals, clinics, and other healthcare organizations, the company can expand its reach and offer its services to a wider audience. This partnership could involve joint ventures, co-marketing agreements, or other collaborative arrangements. The timeline for this opportunity is dependent on the company's ability to establish mutually beneficial relationships with healthcare providers.
- Investment in Artificial Intelligence (AI) for Healthcare: The application of AI in healthcare is rapidly growing, with potential benefits including improved diagnostics, personalized treatment plans, and increased efficiency. Jackson Acquisition Company could invest in AI-powered healthcare solutions to enhance its offerings and gain a competitive advantage. The global AI in healthcare market is projected to reach $45.2 billion by 2026, growing at a CAGR of 44.9%. This investment could position Jackson Acquisition Company as a leader in the healthcare technology space. The timeline for this opportunity is dependent on the company's technological capabilities and market conditions.
- Geographic Expansion into Emerging Markets: Jackson Acquisition Company could explore opportunities to expand its operations into emerging markets, where healthcare spending is growing rapidly. By entering new geographic regions, the company can diversify its revenue streams and tap into new customer bases. This expansion could involve acquisitions, partnerships, or organic growth. The timeline for this opportunity is dependent on the company's strategic priorities and market conditions.
What Opportunities Does RJAC Have?
- Growing demand for healthcare services and technology
- Increasing number of private companies seeking to go public
- Potential for strategic partnerships and collaborations
- Expansion into new geographic markets
What Threats Does RJAC Face?
- Economic downturn or market volatility
- Changes in regulatory environment
- Failure to identify or complete a suitable acquisition
- Increased competition from other SPACs
What Are RJAC's Competitive Advantages?
- Management team's experience in deal sourcing and execution.
- Focus on the high-growth healthcare services and healthcare technology sectors.
- Access to capital through the public markets.
What Does RJAC Do?
Jackson Acquisition Company, established in 2021 and headquartered in Alpharetta, Georgia, operates as a blank check company, also known as a special purpose acquisition company (SPAC). The company's primary objective is to identify and merge with a private company, effectively taking the target public without the traditional initial public offering (IPO) process. Jackson Acquisition Company focuses its search on businesses within the healthcare services and healthcare technology sectors, aiming to capitalize on the growing demand and innovation in these areas. The company's strategy involves leveraging its management team's expertise and network to source, evaluate, and execute a business combination that delivers value to its shareholders. As a SPAC, Jackson Acquisition Company holds investor funds in escrow until an acquisition is completed, providing a level of security and transparency. The successful completion of a merger or acquisition is critical to the company's long-term success and shareholder returns. The company's current market capitalization stands at $0.29 billion, reflecting investor expectations and market sentiment regarding its acquisition prospects.
What Products and Services Does RJAC Offer?
- Jackson Acquisition Company is a blank check company.
- The company aims to effect a merger with one or more businesses.
- It may also pursue a share exchange with another company.
- The company may acquire assets from another business.
- It can purchase stock in another company.
- Jackson Acquisition Company may also pursue a reorganization with another company.
- The company intends to focus on businesses in the healthcare services and healthcare technology sectors.
How Does RJAC Make Money?
- Jackson Acquisition Company raises capital through an initial public offering (IPO).
- The company seeks to identify and merge with a private company in the healthcare services or healthcare technology sectors.
- Upon completion of a merger, the private company becomes publicly traded.
What Industry Does RJAC Operate In?
Jackson Acquisition Company operates within the shell company industry, specifically as a special purpose acquisition company (SPAC). The SPAC market has experienced significant growth in recent years, driven by the desire of private companies to go public more quickly and with less regulatory scrutiny than traditional IPOs. The competitive landscape includes numerous SPACs seeking acquisition targets across various sectors. Jackson Acquisition Company's focus on healthcare services and technology positions it within a high-growth area, but also increases competition for attractive targets. The success of SPACs depends on their ability to identify and merge with companies that can deliver strong financial performance and create shareholder value.
Who Are RJAC's Key Customers?
- Jackson Acquisition Company's initial customers are investors who participate in its IPO.
- The company's ultimate customers are the shareholders of the company it merges with.
- The target company's customers are the end-users of the healthcare services or technology provided.
How Jackson Acquisition Company Is Valued
Jackson Acquisition Company carries a market capitalization of $288.97M, placing it in the micro-cap category. Relative to its peer group, RJAC's quantitative score of 44/100 is roughly in line with the peer average of 49/100.
ROE 6%Key Financial Metrics
Return on equity for Jackson Acquisition Company stands at 5.6%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 5.0%, showing how much profit it generates from its asset base. RJAC trades at a trailing price-to-earnings ratio of 25.12, above the Financial Services sector average of ~18x. Its free cash flow yield is -0.6%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.53 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 4.0%, the inverse of the P/E and a quick read on earnings relative to price.
F-Score 2/9Financial Health
Jackson Acquisition Company's Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 17.71 places it in the safe zone, indicating low near-term bankruptcy risk.
RJAC Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Experienced management team
- Focus on high-growth sectors
- Access to public capital markets
- Flexibility to pursue various transaction structures
Bear Case
- Dependence on identifying and completing a successful acquisition
- Competition from other SPACs
- Potential for dilution of shareholder value
- Limited operating history
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
RJAC Latest News
No recent news available for RJAC.
RJAC Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for RJAC.
Price Targets
Wall Street price target analysis for RJAC.
RJAC MoonshotScore
What does this score mean?
The MoonshotScore rates RJAC's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Classification
Industry Shell CompaniesLeadership: Richard Lee Jackson
CEO
Richard Lee Jackson is the Chief Executive Officer of Jackson Acquisition Company. His background includes extensive experience in the financial services sector, with a focus on investment banking and mergers and acquisitions. He has held leadership positions at various financial institutions, where he was responsible for advising companies on strategic transactions and capital raising. His expertise spans across multiple industries, including healthcare, technology, and consumer products. He has a proven track record of successfully executing complex deals and creating value for shareholders.
Track Record: Under Richard Lee Jackson's leadership, Jackson Acquisition Company has focused on identifying and evaluating potential acquisition targets within the healthcare services and healthcare technology sectors. His strategic decisions have been centered on maximizing shareholder value through a disciplined approach to deal sourcing and execution. He has overseen the company's efforts to build a strong network of advisors and partners to support its acquisition strategy. The company's progress in identifying and evaluating potential targets reflects his commitment to delivering long-term value to investors.
Common Questions About RJAC (Financial Services)
What does Jackson Acquisition Company do?
Jackson Acquisition Company is a special purpose acquisition company (SPAC) that aims to merge with a private company, effectively taking it public. The company focuses on identifying businesses in the healthcare services and healthcare technology sectors. By merging with a high-growth company in these areas, Jackson Acquisition Company seeks to deliver value to its shareholders through the acquired company's future performance. The company's business model involves raising capital through an IPO, identifying a target company, and completing a merger or acquisition.
What are the main risks for RJAC?
The primary risk for Jackson Acquisition Company is the failure to identify and complete a suitable acquisition within the specified timeframe, which could lead to liquidation and return of capital to shareholders. Other risks include increased competition from other SPACs for attractive targets, economic downturn or market volatility impacting the valuation of potential acquisition targets, and changes in the regulatory environment affecting the SPAC market and healthcare industry. The company's success depends on its ability to navigate these risks and execute a favorable transaction.
What regulatory challenges does Jackson Acquisition Company face?
As a special purpose acquisition company (SPAC), Jackson Acquisition Company faces regulatory challenges related to securities laws, disclosure requirements, and compliance with listing standards. The company must adhere to strict regulations regarding the use of investor funds, the identification and evaluation of potential acquisition targets, and the completion of a merger or acquisition. Compliance costs can be significant, and failure to comply with regulations could result in penalties or legal action. The company's ability to navigate the regulatory environment is crucial to its success.
How is Jackson Acquisition Company adapting to fintech disruption?
While Jackson Acquisition Company operates in the financial services sector as a SPAC, its focus on healthcare services and healthcare technology means that its adaptation to fintech disruption is indirect. The company's potential acquisition targets in the healthcare space may be impacted by fintech innovations such as digital payment solutions, telemedicine platforms, and AI-powered healthcare analytics. Jackson Acquisition Company must assess how these fintech trends are shaping the competitive landscape and identify companies that are well-positioned to leverage or adapt to these changes. The company's investment decisions should consider the impact of fintech on the healthcare industry.
What are the key factors to evaluate for RJAC?
Jackson Acquisition Company (RJAC) holds an AI score of 44/100 (low). Not financial advice.
How frequently does RJAC data refresh on this page?
RJAC prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven RJAC's recent stock price performance?
Jackson Acquisition Company (RJAC) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Experienced management team. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider RJAC overvalued or undervalued right now?
Valuing Jackson Acquisition Company (RJAC) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- AI analysis is pending for RJAC, which may provide additional insights.
- The success of Jackson Acquisition Company depends on its ability to identify and complete a successful acquisition, which is subject to various risks and uncertainties.